A Comparison of DTI‐Based Measures as Predictors of Future Cerebrovascular Degeneration
Robert I. Reid(Mayo Clinic), Prashanthi Vemuri(Mayo Clinic in Arizona), Scott A. Przybelski(Mayo Clinic in Florida), Sheelakumari Raghavan(Mayo Clinic), Timothy G. Lesnick(Mayo Clinic in Florida), Michael G. Kamykowski(Mayo Clinic), Angela J. Fought(Mayo Clinic in Florida), David S. Knopman(Mayo Clinic in Arizona), Clifford R. Jack(Mayo Clinic), Ronald C. Petersen(University of California, Los Angeles), Jonathan Graff‐Radford(Mayo Clinic in Arizona)
Cited by 0
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment
|Journal of Internal Medicine|2004|5k
Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
|Alzheimer s & Dementia|2024|2.3k